Gennova Biopharmaceuticals Ltd., headquartered in Pune, India, is a biotechnology company dedicated to developing, producing, and commercializing biotherapeutics to address life-threatening diseases across various indications.
Gennova is transforming healthcare by creating efficient and effective solutions for manufacturing and successfully commercializing bio-therapeutics across cardiovascular, neurology, nephrology, and oncology segments. Incorporating recombinant DNA technologies and innovative bio-manufacturing practices The company manufactures its recombinant products using bacterial, yeast, and mammalian-based expression platforms and has developed deep expertise in perfusion-based continuous manufacturing technologies. To date, Gennova has commercialized nine products; 5 biosimilars, one generic, and one pioneering – ‘first in the world’ product. Gennova has also developed an mRNA-based platform technology for a COVID-19 vaccine.
